India, May 07 : A new targeted cancer therapy has shown encouraging results in late stage clinical trials conducted across multiple countries.
The treatment focuses on precision targeting of malignant cells while minimizing damage to healthy tissue, significantly reducing side effects compared to traditional chemotherapy.
Researchers believe the therapy could become a standard treatment option within the next few years pending regulatory approval.